Skip to content
10-Q

Quarterly Report

CALUMET SPECIALTY PRODUCTS PARTNERS, L.P.

0001340122-24-000042

← back to feed
Filed
May 10, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 10, 2024 80.39M sh
Shares Diluted Q1 2024 · Mar 31, 2024 80.35M sh
Shares Diluted Q1 2024 · Mar 31, 2023 79.94M sh
Capex Q1 2024 · Mar 31, 2024 $20M
Capex Q1 2024 · Mar 31, 2023 $130.4M
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$94M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$26.7M
Long Term Debt Q1 2024 · Mar 31, 2024 $2.06B
Long Term Debt Q1 2024 · Dec 31, 2023 $1.83B
Cash And Equivalents Q1 2024 · Mar 31, 2024 $23.9M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $7.9M
Cash And Equivalents Q1 2024 · Mar 31, 2023 $11.2M
Current Liabilities Q1 2024 · Mar 31, 2024 $824.4M
Current Liabilities Q1 2024 · Dec 31, 2023 $1.11B
Total Liabilities Q1 2024 · Mar 31, 2024 $3.02B
Total Liabilities Q1 2024 · Dec 31, 2023 $3B
Current Assets Q1 2024 · Mar 31, 2024 $811.7M
Current Assets Q1 2024 · Dec 31, 2023 $794.7M
Total Assets Q1 2024 · Mar 31, 2024 $2.73B
Total Assets Q1 2024 · Dec 31, 2023 $2.75B
Net Income Q1 2024 · Mar 31, 2024 −$41.6M
Net Income restated Q1 2024 · Mar 31, 2023 $18.6M
Operating Income Q1 2024 · Mar 31, 2024 $36.3M
Operating Income restated Q1 2024 · Mar 31, 2023 $43M
Gross Profit Q1 2024 · Mar 31, 2024 $78.5M
Gross Profit restated Q1 2024 · Mar 31, 2023 $96.6M
Cost Of Revenue Q1 2024 · Mar 31, 2024 $927.3M
Cost Of Revenue restated Q1 2024 · Mar 31, 2023 $940.7M
Revenue Q1 2024 · Mar 31, 2024 $1.01B
Revenue restated Q1 2024 · Mar 31, 2023 $1.04B